L20.9: Atopic dermatitis, unspecified

The ICD-10-CM code for atopic dermatitis documented without a named subtype such as flexural, infantile or intrinsic eczema.

Billable

FY2027

TABLE OF CONTENTS

Example H2

Medical scribe app interface showing a recording waveform, a list of patient notes, and a SOAP note for John Doe.

Stop looking up codes.

Scribe auto-generates them for you.

Try Commure Scribe →

At a glance

Code Family

L20: Atopic dermatitis

Condition

Atopic dermatitis

Family Specificity

Seven billable codes sit under L20. The five codes under L20.8- each name a subtype. L20.9 is the residual code.

DRG Grouping

MS-DRG 606 or 607, minor skin disorders, in MDC 09 under the FY2027 MS-DRG v44 grouper.

HCC Mapping (v28)

None. No code in category L20 maps to a payment HCC in the CMS-HCC V28 model.

Billable

Yes. L20.9 is a valid code for submission.

Which L20 code do I assign?

The L20 family splits on the named clinical subtype the record states. It does not split on severity, body site or laterality. A severe or widespread presentation stays on the same code as a mild one unless a subtype is named.

When documentation says…

Code

Besnier's prurigo

L20.0

Besnier's prurigo. The tabular places this eponym inside category L20, atopic dermatitis. Assign it only where the record uses that term.

Atopic neurodermatitis

L20.81

Atopic neurodermatitis. The Index sends Neurodermatitis, atopic and Neurodermatitis, diffuse (Brocq) here. Lichenification, circumscribed neurodermatitis and lichenified eczema index to L28.0, lichen simplex chronicus.

Eczema of the antecubital and popliteal folds

L20.82

Flexural eczema. The note must locate the disease at flexural sites.

Infantile eczema

L20.83

Infantile (acute) (chronic) eczema. The Alphabetic Index subterm Eczema, infantile leads here. Acute and chronic are nonessential modifiers inside the descriptor and are not separate documentation requirements.

Intrinsic eczema

L20.84

Intrinsic (allergic) eczema. The note must use the term intrinsic. The parenthetical (allergic) is part of the official descriptor and adds no further documentation requirement.

Atopic dermatitis of a specified type not listed above

L20.89

Other atopic dermatitis. The Alphabetic Index subterm Dermatitis, atopic, specified NEC leads here. The note must name a subtype that no other L20 code covers.

Atopic dermatitis, no subtype stated

L20.9

Atopic dermatitis, unspecified. The note records atopic dermatitis or atopic eczema and stops there. Severity, affected site and chronicity do not move the encounter off L20.9.

Tabular notes

EXCLUDES2

Category L20 carries no Excludes1 note and no Excludes2 note of its own. L20.9 carries none either. Apart from the Chapter 12 Excludes2 list, the instructional text that reaches L20.9 sits at the L20–L30 block heading. That heading also carries the note "In this block the terms dermatitis and eczema are used synonymously and interchangeably." The block Excludes2 list reads: chronic (childhood) granulomatous disease (D71-), dermatitis gangrenosa (L08.0), dermatitis herpetiformis (L13.0), dry skin dermatitis (L85.3), factitial dermatitis (L98.1), perioral dermatitis (L71.0), radiation-related disorders of the skin and subcutaneous tissue (L55–L59), and stasis dermatitis (I87.2). Excludes2 means the two conditions may co-exist. Both codes may be reported when both are documented. Subcategory L20.8 carries one further Excludes2 note, for circumscribed neurodermatitis (L28.0).

FY2027: EFFECTIVE 1 OCTOBER 2026

L20.9 is unchanged in the FY2027 update, effective 1 October 2026. The FY2027 codes addenda add, delete or revise no code in category L20 or elsewhere in block L20–L30. The FY2027 tabular addenda change no note in the L20 hierarchy or at the block heading. L20.9 is in the FY2027 billable code list.

Operational & financial impact

Why specificity matters beyond the chart: risk adjustment, DRG assignment and denial exposure all follow from which code is selected.

CMS-HCC v28 (PY2024+)

L20.9 does not map to a payment HCC in the CMS-HCC V28 model.

The skin and subcutaneous tissue categories in V28 are limited to pressure and chronic ulcers (HCC 379 through HCC 383), severe skin burn (HCC 385), and pemphigus, pemphigoid and other specified autoimmune skin disorders (HCC 387). The model carries no dermatitis or eczema category.

V28 is the 2024 CMS-HCC model. CMS calculates 100 percent of Medicare Advantage risk scores from it for payment year 2026.

Moving from L20.9 to a named L20.8- subtype does not change risk adjustment. No code in category L20 maps to a V28 HCC.

MS-DRG v44 (FY2027)

MS-DRG 606: minor skin disorders with MCC.

MS-DRG 607: minor skin disorders without MCC.

L20.9 as a principal diagnosis groups to MS-DRG 606 or 607 in MDC 09, diseases and disorders of the skin, subcutaneous tissue and breast.

That pair splits on whether a major complication or comorbidity is documented elsewhere in the record. It does not split on which L20 code is selected.

Medicare and commercial payers

There is no National Coverage Determination specific to atopic dermatitis diagnosis coding.

Category L20 has no severity axis. Severity, affected body surface area and failure of prior topical therapy belong in the note and on the prior authorization, not in the diagnosis code.

Z79.620 and Z79.899 are status codes. Section I.C.21.c.3 lists category Z79 among the status Z codes.

WHERE SPECIFICITY IS LOST

Unqualified eczema does not support L20.9. The Alphabetic Index main term Eczema, with its nonessential modifiers (acute) (chronic) (erythematous) (fissum) (rubrum) (squamous), leads to L30.9. The tabular lists Eczema NOS as an inclusion term under L30.9. Assigning L20.9 from a note that says only eczema asserts an atopic diagnosis the record does not state.

A note that locates the disease at flexural sites, records infantile onset, states an intrinsic phenotype or documents atopic neurodermatitis supports one of the L20.8- codes. L20.9 carries none of that detail forward.

Categories L23, L24 and L25 each carry an Excludes1 note for dermatitis NOS (L30.9). Where an allergen or irritant exposure is documented, the contact dermatitis code replaces L30.9 rather than accompanying it. No Excludes1 note prohibits reporting L20.9 together with a code from L23–L25. Atopic dermatitis and contact dermatitis may both be reported where the record documents both.

Registry reporting, quality measurement and payer prior authorization review read the chart rather than the diagnosis code. The unspecified code is defensible when the note genuinely says no more. Section I.B.18 of the ICD-10-CM Official Guidelines instructs that unspecified codes be reported when they most accurately reflect what is known about the condition. The test is what the record supports at that particular encounter.

Documentation checklist to support L20.9

Chart elements that support code selection and reduce specificity-driven denials.

A provider statement of atopic dermatitis or atopic eczema, rather than eczema alone.

Any named subtype the provider records. Flexural, infantile, intrinsic and neurodermatitis presentations each carry their own code in the L20.8- range.

The distribution and body sites involved, which is what separates L20.82 from the residual code.

Age at onset, for the infantile presentations that route to L20.83.

Whether allergen sensitization was tested or documented, which bears on the intrinsic versus extrinsic distinction behind L20.84.

Any secondary bacterial or viral infection, with the organism where it was identified, to support L08.9, L01.1, B00.0 or an organism code alongside the dermatitis code.

Current systemic therapy named by drug class, to support the correct Z79 status code.

A confirmed diagnosis for outpatient encounters. Probable or suspected atopic dermatitis is not coded in the outpatient setting.

A provider query where the record says eczema and nothing further. L30.9 and L20.9 sit in different ICD-10-CM categories.

FAQ

Is L20.9 a billable code?

Yes. L20.9 is a valid code for submission under the FY2027 code set, effective 1 October 2026. Category L20 and subcategory L20.8 are headers rather than complete codes. Neither of those is billable.

The note says eczema. Can I assign L20.9?

L20.9 cannot be assigned on that wording alone. The Alphabetic Index main term Eczema, carrying the nonessential modifiers (acute) (chronic) (erythematous) (fissum) (rubrum) (squamous), leads to L30.9, dermatitis unspecified. The tabular prints Eczema NOS as an inclusion term under L30.9. L20.9 requires the record to state that the dermatitis is atopic. The L20–L30 block note that dermatitis and eczema are synonymous governs the two words, not the specificity of the diagnosis.

Which code is nearest to L20.9 and most easily confused with it?

The nearest code is L30.9, dermatitis unspecified. It is where the Alphabetic Index sends unqualified eczema and unqualified dermatitis. L28.0, lichen simplex chronicus, is the other near neighbor. Its inclusion terms are circumscribed neurodermatitis and lichen NOS. Subcategory L20.8 carries an Excludes2 note pointing to it.

Does L20.9 map to an HCC?

No. No code in category L20 maps to a payment HCC in the CMS-HCC V28 model. V28 is the 2024 CMS-HCC model. CMS calculates 100 percent of Medicare Advantage risk scores from it for payment year 2026. The skin categories in V28 cover pressure and chronic ulcers, severe skin burn, and specified autoimmune skin disorders only.

What does the note have to show to support an L20.8- code instead?

The note has to name a subtype. Flexural involvement supports L20.82. Infantile onset supports L20.83. An intrinsic phenotype supports L20.84. Atopic neurodermatitis supports L20.81. A subtype that is named but is covered by none of those supports L20.89.

How do I sequence L20.9 with a secondary skin infection?

Sequence on the reason for the encounter. Where the visit is driven by the superinfection, the infection code leads. L20.9 follows as an additional diagnosis. L01.1, impetiginization of other dermatoses, is the code for a secondarily impetiginized dermatitis. L08.9 covers an unspecified local infection of skin and subcutaneous tissue. Add a code from B95 or B96 when the organism is identified. Add B00.0, eczema herpeticum, where herpes simplex superinfection is documented.

Does the care setting change how L20.9 is used?

The code itself is the same in both settings. Outpatient coding requires a confirmed diagnosis. Probable or suspected atopic dermatitis is not coded there. Inpatient coding may report a diagnosis documented as uncertain at discharge as though it were confirmed, under UHDDS rules. Where L20.9 is the principal diagnosis on an inpatient stay it groups to MS-DRG 606 or 607.

Did anything change for L20.9 in FY2027?

L20.9 is unchanged in the FY2027 update, effective 1 October 2026. The update leaves category L20 and its notes unchanged. Category L20 also gained no codes and lost none for FY2026, which took effect 1 October 2025. No Excludes note in the L20 hierarchy changed that year.

Related codes

Codes in the same family as L20.9. Only codes with a published page render as links.

Sibling codes in the L20 family

L20.0: Besnier's prurigo.
L20.81: Atopic neurodermatitis.
L20.82: Flexural eczema.
L20.83: Infantile (acute) (chronic) eczema.
L20.84: Intrinsic (allergic) eczema.
L20.89: Other atopic dermatitis.

Additional codes to consider

Codes outside the L20 family considered alongside L20.9.

Companion: code alongside when documented

L08.9: Local infection of the skin and subcutaneous tissue, unspecified. Use for a documented secondary skin infection where no more specific code applies.
L01.1: Impetiginization of other dermatoses. Use where the atopic dermatitis is secondarily impetiginized.
B95.61: Methicillin susceptible Staphylococcus aureus infection as the cause of diseases classified elsewhere.
B95.62: Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere.
B96.89: Other specified bacterial agents as the cause of diseases classified elsewhere.
B00.0: Eczema herpeticum. The inclusion term is Kaposi's varicelliform eruption.
Z79.620: Long term (current) use of immunosuppressive biologic. Inclusion terms cover monoclonal antibodies, adalimumab, etanercept and infliximab.
Z79.621: Long term (current) use of calcineurin inhibitor. Inclusion terms are cyclosporine and tacrolimus.
Z79.622: Long term (current) use of Janus kinase inhibitor.
Z79.52: Long term (current) use of systemic steroids.
Z79.899: Other long term (current) drug therapy. The residual long term drug therapy code, for a systemic agent that no other Z79 subcategory names. Assign Z79.620 in preference where the agent is an immunosuppressive biologic.

Consider instead

L30.9: Dermatitis, unspecified. This is the code the Alphabetic Index reaches from unqualified eczema. Its inclusion term is Eczema NOS.
L23.9: Allergic contact dermatitis, unspecified cause. Category L23 carries an Excludes1 note for dermatitis NOS (L30.9).
L24.9: Irritant contact dermatitis, unspecified cause. Category L24 carries an Excludes1 note for dermatitis NOS (L30.9).
L25.9: Unspecified contact dermatitis, unspecified cause. Use where contact is documented but neither an allergic nor an irritant mechanism is stated.
L21.9: Seborrheic dermatitis, unspecified. Category L21 carries an Excludes2 note for infective dermatitis (L30.3) and one for seborrheic keratosis (the L82 codes).
L28.0: Lichen simplex chronicus. Inclusion terms are circumscribed neurodermatitis and lichen NOS.
L30.0: Nummular dermatitis.
L30.2: Cutaneous autosensitization. Inclusion terms include eczematid.
L30.3: Infective dermatitis. The inclusion term is infectious eczematoid dermatitis.
L85.3: Xerosis cutis. The inclusion term is dry skin dermatitis. The L20–L30 block carries an Excludes2 note for it.
L20.89: Other atopic dermatitis. Use where a subtype is named but no other L20 code covers it.

Sources

All claims on this page derive from government and professional-standards sources.

National Center for Health Statistics. (2026). International classification of diseases, tenth revision, clinical modification (ICD-10-CM) FY2027 files. https://www.cdc.gov/nchs/icd/icd-10-cm/files.html
Centers for Medicare & Medicaid Services and National Center for Health Statistics. (2026). ICD-10-CM official guidelines for coding and reporting FY2027. https://ftp.cdc.gov/pub/Health_Statistics/NCHS/Publications/ICD10CM/2027/ICD-10-CM-October-1-2026-FY27-Guidelines.pdf
Centers for Medicare & Medicaid Services. (2025). 2026 model software/ICD-10 mappings. https://www.cms.gov/medicare/payment/medicare-advantage-rates-statistics/risk-adjustment/2026-model-software-icd-10-mappings
Centers for Medicare & Medicaid Services. (2026). MS-DRG classifications and software, version 44. https://www.cms.gov/medicare/payment/prospective-payment-systems/acute-inpatient-pps/ms-drg-classifications-and-software